<p>Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy. In particular, the approval of novel and first-in-class drugs such as thalidomide,
Multiple Myeloma - An Overview
β Scribed by A. Gupta
- Publisher
- Intech
- Year
- 2011
- Tongue
- English
- Leaves
- 284
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Table of Contents
00 preface_ Multiple Myeloma - An Overview......Page 1
Part 1_ Multiple Myeloma Disease Biology and it's Therapeutic Applications......Page 11
01_ Proteasome Inhibitors in the Treatment
of Multiple Myeloma......Page 13
02_ Regulatory Cells and Multiple Myeloma......Page 43
03_ Effects of Recombinant Human Tumor Necrosis
Factor-Ξ± and Its Combination with Native
Human Leukocyte Interferon-Ξ± on P3-X63-
Ag8.653 Mouse Myeloma Cell Growth......Page 71
04_ Cellular Immunotherapy Using Dendritic
Cells Against Multiple Myeloma......Page 85
05_ Targeted Inhibition of Multiple Proinflammatory
Signalling Pathways for the Prevention
and Treatment of Multiple Myeloma......Page 103
06_ The SUMOylation Pathway as a Potential
Therapeutic Target in Multiple Myeloma......Page 139
07_ Therapeutic Approaches for Targeting Hypoxia-
Inducible Factor in Multiple Myeloma......Page 147
08_ The Contribution of Prognostic Factors
to the Better Management of
Multiple Myeloma Patients......Page 155
Part 2_ Multiple Myeloma Management Issues and Considerations......Page 185
09_ Solitary Plasmacytoma of Bone......Page 187
10_ Solitary Bone and Extramedullary
Plasmacytoma......Page 195
11_ Multiple Myeloma and Dentistry......Page 217
12_ Renal Disease in Multiple Myeloma......Page 229
13_ Stem Cell MobΔ±lΔ±zatΔ±on in MultΔ±ple Myeloma......Page 251
14_ The Current Role of Stem Cell
Transplantation in Multiple Myeloma......Page 273
π SIMILAR VOLUMES
<p><p>This volume provides a thorough guide of the study of multiple myeloma (MM)βfrom sample acquisition to the performance of molecular tests, and also discusses difficulties that arise during quality control and interpretation of results. The chapters in this book cover topics, such as next-gener
<p>Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy. In particular, the approval of novel and first-in-class drugs such as thalidomide,
<p>This handbook is an in-depth and comprehensive guide to the pathophysiology, diagnosis, staging, treatment and management of patients with multiple myeloma. The Handbook was commissioned to address an unmet need for a book of this kind in the myeloma field and to provide busy healthcare professio
<p>Although there is no therapy that could be considered curative for patients with multiple myeloma, recent research has gained considerable momentum and yielded a real prospect for achieving a significant improvement in response to therapy. In Multiple Myeloma: Methods and Protocols, established r